)
Euglena (2931) investor relations material
Euglena Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q1 FY2026 sales rose 11% year-over-year to ¥13,197 million, led by Healthcare business growth.
Adjusted EBITDA increased 18% YoY to ¥1,822 million; operating profit up 35% YoY to ¥837 million.
Net loss narrowed sharply YoY, with net income at -¥32 million versus -¥507 million last year.
Healthcare B2C subscribers exceeded 710,000, with strong growth in child-rearing nutrition products.
Ordinary profit rose to ¥782 million, up 79.3% YoY.
Financial highlights
Sales: ¥13,197 million (+11% YoY); Healthcare sales: ¥12,189 million (+12% YoY).
Adjusted EBITDA: ¥1,822 million (+18% YoY); Operating profit: ¥837 million (+35% YoY).
Gross profit for Q1 2026 was ¥8,992 million, up from ¥8,335 million in Q1 2025.
Comprehensive income attributable to owners of parent improved to ¥140 million from a loss of ¥924 million YoY.
Equity-to-asset ratio improved to 46.4% from 42.7% at the previous year-end.
Outlook and guidance
Progress is slightly ahead of the annual earnings forecast, but full-year guidance remains unchanged due to planned ad spend expansion and Middle East geopolitical uncertainty.
Fiscal year 2026 net sales forecast at ¥52,000 million, up 3.2% YoY; operating profit projected at ¥3,200 million.
No revisions to previously announced earnings or dividend forecasts.
Continued focus on achieving net income profitability for the full year.
- Record sales and profit turnaround achieved, with further growth targeted for FY2025.2931
Q4 202412 May 2026 - Profitability returned in 1H FY2024, with sales growth and improved equity and asset positions.2931
Q2 202412 May 2026 - Sales and profitability improved YoY, with strong adjusted EBITDA and higher equity ratio.2931
Q3 202412 May 2026 - Sales and profits rose sharply, but the quarter ended with a net loss due to restructuring costs.2931
Q1 202512 May 2026 - Operating profit surged eightfold on higher sales, with upward guidance and biorefinery investment.2931
Q2 202512 May 2026 - Profits surged on healthcare growth and cost cuts, with FY2025 guidance raised again.2931
Q3 202512 May 2026 - Record sales and profit surge in FY2025, with strong outlook and special dividend declared.2931
Q4 202512 May 2026
Next Euglena earnings date
Next Euglena earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)